About
Lipp Life Sciences LLC was founded by Ralph Lipp, Ph.D. in 2012 and is located in the Miami Metropolitan Area, Florida, USA.
Lipp Life Sciences LLC was founded by Ralph Lipp, Ph.D. in 2012 and is located in the Miami Metropolitan Area, Florida, USA.
Ralph Lipp, Ph.D.
President & CEO
Lipp Life Sciences LLC
President & CEO
Lipp Life Sciences LLC
Ralph Lipp, Ph.D., President & CEO of Lipp Life Sciences LLC, has been serving in leadership positions in the life sciences industry for more than 30 years. As Chief Scientific Officer at Noven Pharmaceuticals Ralph provided leadership to all research and development areas. At Schering in Germany and later at Eli Lilly in the US he headed various R&D functions with increasing responsibility for people and budget – up to 450 FTEs and up to $250 million.
Ralph’s expertise covers new chemical entities, biologics, devices, combination products and the areas of medicinal chemistry, pharmaceutical R&D and drug delivery, process development, analytical R&D, toxicology, clinical pharmacology, clinical R&D, regulatory affairs and pharmacovigilance, medical affairs, and commercial. His scientific contributions comprise more than 140 publications, including over 20 patents, covering five marketed medicines with aggregate peak annual sales exceeding $1 billion.
Ralph is a pharmacist and holds a Ph.D. in Medicinal Chemistry and a Habilitation for Pharmaceutical Technology from Free University Berlin, Germany. He graduated from the International Executive Program, at INSEAD in Fontainebleau, France and from the Advanced Management Program, at Harvard Business School, Boston, MA, USA.
Ralph’s expertise covers new chemical entities, biologics, devices, combination products and the areas of medicinal chemistry, pharmaceutical R&D and drug delivery, process development, analytical R&D, toxicology, clinical pharmacology, clinical R&D, regulatory affairs and pharmacovigilance, medical affairs, and commercial. His scientific contributions comprise more than 140 publications, including over 20 patents, covering five marketed medicines with aggregate peak annual sales exceeding $1 billion.
Ralph is a pharmacist and holds a Ph.D. in Medicinal Chemistry and a Habilitation for Pharmaceutical Technology from Free University Berlin, Germany. He graduated from the International Executive Program, at INSEAD in Fontainebleau, France and from the Advanced Management Program, at Harvard Business School, Boston, MA, USA.